Valuation: Abbott Laboratories

Market Cap 20TCr 3,02,08200Cr 17TCr 16TCr 15TCr 28TCr 19,31100Cr 28TCr 1,91100Cr 75TCr 9,70100Cr 76TCr 74TCr 32,08600Cr P/E 2026 *
33.5x
P/E 2027 * 25.8x
Enterprise Value 23TCr 3,37,91100Cr 19TCr 18TCr 17TCr 31TCr 21,60200Cr 31TCr 2,13800Cr 83TCr 10,85100Cr 85TCr 83TCr 35,89200Cr EV / Sales 2026 *
4.49x
EV / Sales 2027 * 4.08x
Free-Float
86.16%
Yield 2026 *
2.2%
Yield 2027 * 2.35%
1 day+2.48%
1 week+6.04%
Current month+11.19%
1 month+18.47%
3 months+42.70%
6 months+14.14%
Current year-3.06%
1 week 44,180
Extreme 44180
46,420
1 month 39,560
Extreme 39560
46,420
Current year 30,380
Extreme 30380
49,620
1 year 30,380
Extreme 30380
53,525
3 years 18,337
Extreme 18337
53,525
5 years 5,360.5
Extreme 5360.5
53,525
10 years 145
Extreme 145
53,525
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+2.48%+6.04% - - 20TCr
+2.19%+4.84%-11.64%+12.29% 20TCr
+1.14%+2.28%+2.47%+14.39% 12TCr
+1.06%+1.34%+4.88%+75.73% 6.07TCr
-1.37%-6.57%+28.86%+58.31% 5.24TCr
+2.33%+4.69%-2.35%-30.34% 5.23TCr
+2.35%+2.89%+14.54%-11.79% 3.48TCr
+5.16%-4.14% - - 3.01TCr
-0.20%+1.05%+45.52%-10.08% 2.48TCr
-0.29%-3.87%-6.22%+24.74% 2.38TCr
Average +1.48%+0.28%+9.51%+16.66% 6.67TCr
Weighted average by Cap. +1.77%+1.90%+1.97%+17.88%

Financials

2026 *2027 *
Net sales 5.03TCr 75,28700Cr 4.31TCr 4.03TCr 3.69TCr 6.93TCr 4,81300Cr 7.02TCr 48TCr 19TCr 2,41800Cr 19TCr 18TCr 7,99700Cr 5.46TCr 81,78800Cr 4.68TCr 4.38TCr 4.01TCr 7.52TCr 5,22800Cr 7.62TCr 52TCr 20TCr 2,62600Cr 21TCr 20TCr 8,68700Cr
Net income 623.24Cr 9,32800Cr 533.86Cr 499.52Cr 457.26Cr 858.14Cr 60TCr 869.48Cr 5.9TCr 2.3TCr 30TCr 2.34TCr 2.29TCr 99TCr 792.44Cr 11,86000Cr 678.81Cr 635.14Cr 581.4Cr 1.09TCr 76TCr 1.11TCr 7.5TCr 2.93TCr 38TCr 2.98TCr 2.91TCr 1,26000Cr
Net Debt 2.39TCr 35,82900Cr 2.05TCr 1.92TCr 1.76TCr 3.3TCr 2,29000Cr 3.34TCr 23TCr 8.84TCr 1,15100Cr 8.99TCr 8.79TCr 3,80600Cr 2.1TCr 31,36700Cr 1.8TCr 1.68TCr 1.54TCr 2.89TCr 2,00500Cr 2.92TCr 20TCr 7.74TCr 1,00700Cr 7.87TCr 7.7TCr 3,33200Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Date Price Change Volume
21/26/21 ARS 46,320.00 +2.48% 4,304
20/26/20 ARS 45,200.00 +0.27% 1,574
19/26/19 ARS 45,080.00 +1.30% 4,070
18/26/18 ARS 44,500.00 +1.88% 4,220
14/26/14 ARS 43,680.00 -0.86% 1,705
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
116.64USD
Average target price
120.20USD
Spread / Average Target
+3.05%

Quarterly revenue - Rate of surprise